18 January 2017 - Patient advocacy groups should be forced to declare their commercial funding, with a growing body of evidence raising serious concerns over conflicts of interests, Australian experts say.

Health consumer groups have become powerful global players in healthcare, capable of promoting certain interventions, steering research funding and shaping public debate from a public platform of altruism.

Read Sydney Morning Herald article